EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS197-11188 
Organism
Homo sapiens 
Tissue/cell
ZR75-30 
Coordinate
chr2:20435190-20436670 
Target genes
TF binding sites/motifs
Number: 51             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr2:20436256-20436274CCTTCCTTCCCACCCTTC-6.03
EWSR1-FLI1MA0149.1chr2:20436268-20436286CCCTTCTTCCCTCCCTCC-6.04
EWSR1-FLI1MA0149.1chr2:20436272-20436290TCTTCCCTCCCTCCCTCC-6.16
EWSR1-FLI1MA0149.1chr2:20436244-20436262CTTCCTTCCCTTCCTTCC-6.1
EWSR1-FLI1MA0149.1chr2:20436199-20436217CTTTCCTTCTTTCCTCTC-6.24
EWSR1-FLI1MA0149.1chr2:20436308-20436326TACTTCTTCCTTCCTTCC-6.32
EWSR1-FLI1MA0149.1chr2:20436243-20436261CCTTCCTTCCCTTCCTTC-6.33
EWSR1-FLI1MA0149.1chr2:20436183-20436201CCTTTCTTCTTTCCTTCT-6.47
EWSR1-FLI1MA0149.1chr2:20436175-20436193CCTTTCTTCCTTTCTTCT-6.64
EWSR1-FLI1MA0149.1chr2:20436219-20436237CCTCCCTTCCTTCCCACC-6.6
EWSR1-FLI1MA0149.1chr2:20436227-20436245CCTTCCCACCCTCCTTCC-6.78
EWSR1-FLI1MA0149.1chr2:20436281-20436299CCTCCCTCCCTTCCTCCC-6.92
EWSR1-FLI1MA0149.1chr2:20436223-20436241CCTTCCTTCCCACCCTCC-6.94
EWSR1-FLI1MA0149.1chr2:20436191-20436209CTTTCCTTCTTTCCTTCT-6.95
EWSR1-FLI1MA0149.1chr2:20436187-20436205TCTTCTTTCCTTCTTTCC-6.96
EWSR1-FLI1MA0149.1chr2:20436231-20436249CCCACCCTCCTTCCTTCC-7.03
EWSR1-FLI1MA0149.1chr2:20436277-20436295CCTCCCTCCCTCCCTTCC-7.08
EWSR1-FLI1MA0149.1chr2:20436171-20436189TCTTCCTTTCTTCCTTTC-7.18
EWSR1-FLI1MA0149.1chr2:20436215-20436233TCTCCCTCCCTTCCTTCC-7.25
EWSR1-FLI1MA0149.1chr2:20436293-20436311CCTCCCTTCCTTCCTTAC-7.82
EWSR1-FLI1MA0149.1chr2:20436195-20436213CCTTCTTTCCTTCTTTCC-7.85
EWSR1-FLI1MA0149.1chr2:20436252-20436270CCTTCCTTCCTTCCCACC-7.87
EWSR1-FLI1MA0149.1chr2:20436297-20436315CCTTCCTTCCTTACTTCT-7.88
EWSR1-FLI1MA0149.1chr2:20436179-20436197TCTTCCTTTCTTCTTTCC-7
EWSR1-FLI1MA0149.1chr2:20436285-20436303CCTCCCTTCCTCCCTTCC-8.06
EWSR1-FLI1MA0149.1chr2:20436239-20436257CCTTCCTTCCTTCCCTTC-8.32
EWSR1-FLI1MA0149.1chr2:20436312-20436330TCTTCCTTCCTTCCCTCC-8.52
EWSR1-FLI1MA0149.1chr2:20436248-20436266CTTCCCTTCCTTCCTTCC-8.57
EWSR1-FLI1MA0149.1chr2:20436320-20436338CCTTCCCTCCTTCCTTCC-9.09
EWSR1-FLI1MA0149.1chr2:20436235-20436253CCCTCCTTCCTTCCTTCC-9.72
EWSR1-FLI1MA0149.1chr2:20436289-20436307CCTTCCTCCCTTCCTTCC-9.83
EWSR1-FLI1MA0149.1chr2:20436316-20436334CCTTCCTTCCCTCCTTCC-9.93
TFAP2CMA0524.2chr2:20435652-20435664TGCCCTGGGGCA+6.44
TFAP2CMA0524.2chr2:20435652-20435664TGCCCTGGGGCA-7.22
ZNF263MA0528.1chr2:20436202-20436223TCCTTCTTTCCTCTCTCCCTC-6.12
ZNF263MA0528.1chr2:20436227-20436248CCTTCCCACCCTCCTTCCTTC-6.16
ZNF263MA0528.1chr2:20436206-20436227TCTTTCCTCTCTCCCTCCCTT-6.18
ZNF263MA0528.1chr2:20436244-20436265CTTCCTTCCCTTCCTTCCTTC-6.24
ZNF263MA0528.1chr2:20436289-20436310CCTTCCTCCCTTCCTTCCTTA-6.32
ZNF263MA0528.1chr2:20436240-20436261CTTCCTTCCTTCCCTTCCTTC-6.39
ZNF263MA0528.1chr2:20436276-20436297CCCTCCCTCCCTCCCTTCCTC-6.54
ZNF263MA0528.1chr2:20436256-20436277CCTTCCTTCCCACCCTTCTTC-6.61
ZNF263MA0528.1chr2:20436211-20436232CCTCTCTCCCTCCCTTCCTTC-6.67
ZNF263MA0528.1chr2:20436272-20436293TCTTCCCTCCCTCCCTCCCTT-6.85
ZNF263MA0528.1chr2:20436285-20436306CCTCCCTTCCTCCCTTCCTTC-6.93
ZNF263MA0528.1chr2:20436280-20436301CCCTCCCTCCCTTCCTCCCTT-7.27
ZNF263MA0528.1chr2:20436268-20436289CCCTTCTTCCCTCCCTCCCTC-7.49
ZNF263MA0528.1chr2:20436316-20436337CCTTCCTTCCCTCCTTCCTTC-7.58
ZNF263MA0528.1chr2:20436277-20436298CCTCCCTCCCTCCCTTCCTCC-7.9
ZNF263MA0528.1chr2:20436223-20436244CCTTCCTTCCCACCCTCCTTC-8.06
ZNF263MA0528.1chr2:20436312-20436333TCTTCCTTCCTTCCCTCCTTC-8.24
Number of super-enhancer constituents: 10             
IDCoordinateTissue/cell
SE_02914chr2:20435910-20436272Bladder
SE_23108chr2:20435429-20436301Colon_Crypt_1
SE_23761chr2:20435435-20436241Colon_Crypt_2
SE_24805chr2:20435425-20436239Colon_Crypt_3
SE_26530chr2:20435190-20437204Esophagus
SE_35878chr2:20430227-20437683HMEC
SE_50296chr2:20435375-20436284Sigmoid_Colon
SE_56896chr2:20435280-20436289VACO_400
SE_56896chr2:20436326-20436840VACO_400
SE_64257chr2:20435164-20437609NHEK
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr22043535720436253
chr22043578020436055
Number: 1             
IDChromosomeStartEnd
GH02I020230chr22043036820437558
Enhancer Sequence
TTGAACCTAG GAAGCGGAGG TTGCAGTGAG CTGAGATCAT GCCACTGCAC TCCAGCCTAG 60
GCAATGGAGC GAGACTCCAT CTCAAAAAAA GAAAAAAAAA GGAAAAAAAA GAAATGTCAG 120
TATCTACAGA TAAGACTCAA TCTTGTTAGT GGCTGCTTGG GATTCTCTGG TTTGGCTATA 180
TCTTGATTTA TTTAACCATT CCCCTTCTGA TGGGTGCCAT TTTTAAAGGC TTTGCTGTCA 240
CAAACAATAC TGTTGAATAT CCTCACGTGG ACATCGTCCC ACAGCTGACA AACCTTTCTT 300
AGGACAGAAG TGGCCTGGCT GCCTTGGAGG AGATTCTGAG ACCACTGCTA CATTGCTCTC 360
CCCAAACGCT GTGTCTCCAT GGTCCTTTGG ATGCTCTTAA ATTGCAGCGA GCGCCCACTC 420
CCAGCCAGGG CCTGGGGGTG CATGCTGTCC AAGGCAGGGC CCTGCCCTGG GGCAACTGCA 480
ATCTTTGAGT CCTATGATGA GATGGTTCAA GAGCCAGGGG CCCCAGTCCT GGGTTGCAGG 540
GAGGAGTTCA GGGAAGGCTT CCTGGAGGAG TTGACGTCCA GGCAGAAACC TGCCTGCTGA 600
GTAGCAGTTT GTCAGGCAGG GGAGCAAGTG GGCAGGGCTG CTCAAGCTAG GGGAGGACTT 660
GGCCAGCTGA GGCCCTGAAA GGGCCAGGGC CATCTACGCA CCGCTGAGTA ATGGTGTTCC 720
CTAAATGCTC AGGGCAGTGG CTGAAGGGAG TGGCAGTGGG TGGGGATGAC AGGAAGCTGG 780
GGCAACCGGT GAAGGCCTTC ACTGCCAAGC TAAGGAGTGG GAATGTTGCC CAGGGCAAGC 840
GAGAGCCTGA TTACACACCT GAGGAAGTGA GCCATAGGCT GGAGGGGAGA AAGGACCAGT 900
GCCCTGGGAT GGAGGCTGGG TGGGAATTCA CACCTGGCAA GAGCCCACCA GGAGCCAGGC 960
CCTGTGTAAG GAGAAGCCCC CTCTTCCTTT CTTCCTTTCT TCTTTCCTTC TTTCCTTCTT 1020
TCCTCTCTCC CTCCCTTCCT TCCCACCCTC CTTCCTTCCT TCCCTTCCTT CCTTCCCACC 1080
CTTCTTCCCT CCCTCCCTCC CTTCCTCCCT TCCTTCCTTA CTTCTTCCTT CCTTCCCTCC 1140
TTCCTTCCTA AATTAATAGA CCTTTTTTTA AAGAGCAATT TTGGGTTTAC AGAAAAATTG 1200
AGTCATAAGT ACAGGGAGTT CTCATTGACC TCTCCGCACC CTGCCACACA CGGTTTCTCC 1260
TATGGTTAAC CTGTTGCATT GGTGTGATAC ATCTGTTACA ACTGACAAAC CAGTACTGAC 1320
ATGCTCTCAT TCGCTAAGGT CCCTCGTTCA CATCAGACTA CACTCTTGAT GGTGTACACT 1380
CTGTGGGTTT TGACGAATGC ATAATGACAT GTCTCCACCA TTACAGTAGC CTACAGAGCC 1440
TTTCACAGCC CAAAACATTC CTTGTGTCCT CCTACTCATT 1480